Literature DB >> 9247942

Effects of midazolam on pain sensations in the face.

O Nakanishi1, Y Amano, T Ishikawa, M Azuma, Y Imamura.   

Abstract

OBJECTIVES: This study investigated the effects of midazolam, a sedative, on tactile and pain sensations on the skin of the chin. STUDY
DESIGN: Thirty-seven volunteers were segregated into four groups; the first group was the control group; the second to fourth groups were administered 0.025 mg/kg, 0.05 mg/kg, and 0.075 mg/kg of midazolam, respectively, as a bolus injection. All volunteers reclined in a dental chair for the experiment. Tactile and pain sensations were determined over time after injection of midazolam, the former using von Fray thread, the latter using an esthesiometer.
RESULTS: Thresholds of tactile sensitivity and of pain were statistically significantly different from control values at 10 minutes after injection of midazolam in the 0.05 mg/kg group and in the 0.075 mg/kg group.
CONCLUSION: Although 0.025 mg/kg of midazolam produced sedation, at least 0.05 mg/kg of this agent was required to alter the thresholds for perception of tactile and painful stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247942     DOI: 10.1016/s1079-2104(97)90286-9

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  3 in total

1.  GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.

Authors:  Miriam Kunz; Kirsten Elisabeth Scholl; Ulrich Schu; Stefan Lautenbacher
Journal:  Exp Brain Res       Date:  2006-07-01       Impact factor: 1.972

2.  Predominant effects of midazolam for conscious sedation: benefits beyond the early postoperative period.

Authors:  Kotoe Kamata; Satoshi Hagihira; Ryu Komatsu; Makoto Ozaki
Journal:  J Anesth       Date:  2010-09-17       Impact factor: 2.078

3.  Effects of sedation on subjective perception of pain intensity and autonomic nervous responses to pain: A preliminary study.

Authors:  Hongling Kang; Aya Nakae; Hiroshi Ito; Piyasak Vitayaburananont; Takehiro Minamoto; Takashi Ikeda; Mariko Osaka; Takashi Mashimo; Yuji Fujino; Satoshi Hagihira
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.